Nektar Therapeutics (NKTR)
73.73
-0.13
(-0.18%)
USD |
NASDAQ |
Feb 20, 16:00
73.40
-0.33
(-0.45%)
After-Hours: 20:00
Nektar Therapeutics SG&A Expense (Quarterly) : 16.07M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 28.94M |
| Insmed, Inc. | 212.48M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Ironwood Pharmaceuticals, Inc. | 21.91M |
| Lyell Immunopharma, Inc. | 10.69M |